We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nanoscience | LSE:NAN | London | Ordinary Share | KYG6390E1070 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.375 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/2/2008 08:09 | Just on the Toumaz website | spekky | |
31/1/2008 12:52 | Strange that it took over 3 hrs for share price to tick down,probably a pi bailing.Yet to show at time of writing. | spekky | |
31/1/2008 10:16 | Did n't have to wait long did we,but now convinced its not CVS,and its not straightforward selling.Even though its meant to look that way.SAAD increasing will be the ultimate outcome of these shenanigans. | spekky | |
30/1/2008 22:07 | well, let's see if we get an RNS this week .... and / or another interesting large transaction/s this week one 'interesting' point is that present NAN website lists CVS as having 7,400,000 shares - so I presume that is correct being from 'the horses mouth' - but last 'holdings' rns from NAN concerning CVS gives that I can see (20 April 2007) gives them holding 7,850,000 .... am I missing some announcement between then and now.... | don muang | |
30/1/2008 21:16 | See post 289 which refers to a 3.4million rollover. Both items were transacted at below current price so therefore appear as a sell. Now if your still with me,net one off against the other and you will get (you guessed it).Not both sells IMHO ,bit of smoke and mirrors.we'll see.Convinced its not CVS but realise some of you guys know CVS better than me.The obvious effect would be to unsettle the small punter but they'll have to work harder to worry me. | spekky | |
30/1/2008 19:19 | .... and seen mention on CVS thread that the only listed shares Corvus hold/held were CMM and NAN. Getting rid of half million pounds worth of holdings in non-listed companies might have been difficult in present circumstances ..... so looks like they chose NAN | don muang | |
30/1/2008 17:45 | ... well with investment decisions like this (selling NAN at this point), then perhaps the decline in Corvus's share price is justified... | don muang | |
30/1/2008 17:37 | don, could just be spot on with that little snippet. whatever way you look at it CVS has done its dough. 10p i think they paid. | humbugg | |
30/1/2008 17:18 | that's the question ..... if it's a fund holding and they need more 'cash' under prevailing financial climate (or need money for other investments) they might just go for disposing of something that has underperformed and they think won't overperform for the rest of this particular quarter.... ? ... and given two transactions were 7.4m then I'd go for Corvus Capital as the seller as their holding was 7.4m. They're a listed investment company. Their share price peaked at over 26p during 2007 but is now down to 6.75p. So taken against that performance then NAN isn't a bad performer ... !!! So await the disposal rns | don muang | |
30/1/2008 17:06 | why would you knock your holding out at a significant loss if the company was going places??? | humbugg | |
30/1/2008 12:01 | yes,very interesting,the share price would seem to indicate that they've found a home though.Strange that it comes so soon after change of advisor.Are Strand involved we'll see..... | spekky | |
30/1/2008 10:34 | some big unloading being done this morning ... 5.4m shares followed by another 2m - both at 7p ..... wonder if it'll 'spook' any PI's in to selling..... await with interest | don muang | |
24/1/2008 08:12 | Good stuff,a springboard to greater things. | spekky | |
24/1/2008 07:14 | Nanoscience Inc. (`The Group') Toumaz Technology Awarded ISO 13485 Medical Device Quality Management Certification for Sensium Wireless Body Monitoring Platform Toumaz's commitment to the highest quality management standard required for medical device manufacture recognised by independent accrediting body Nanoscience Inc, the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary Toumaz Technology Limited (`Toumaz') has received ISO 13485:2003 certification for its quality management system. ISO 13485 is the regulatory standard for the international medical industry and is closely related to ISO 9000. Toumaz (a leading provider of ultra-low power wireless infrastructure for body monitoring solutions) was assessed and certified as meeting the requirements of this strategically significant standard by independent body SGS, the world's leading verification and certification body. ISO 13485 is a regulatory requirement in a number of international markets for the manufacture of medical devices, and forms the cornerstone for the CE certification of medical products in the EU. Meeting the ISO quality management standard is a crucial milestone in the ongoing commercialisation of Sensium, Toumaz's breakthrough ultra-low power wireless platform for the development of non-intrusive body monitors for healthcare and lifestyle markets. In November 2007, Toumaz took the top honours in the Electronics category of the prestigious Innovation in Engineering Awards - given by The Institution of Engineering and Technology - in recognition of the groundbreaking innovation of the Sensium as an enabling technology for highly valuable medical applications. Keith Errey, COO, Toumaz, commented: "We are delighted that Toumaz has been awarded the important ISO 13485 certification, which demonstrates our absolute commitment to quality throughout the product cycle including the manufacture of medical devices, and which will offer significant benefits to our customers." The unique combination of ultra-low power wireless and signal processing in one small System-on-Chip (SOC) allows the economies of scale of the semiconductor industry to be harnessed to provide highly functional, robust, low cost, disposable and non-intrusive monitors for a wide range of healthcare applications. The Sensium sensor interface and transceiver platform enables real-time, intelligent, ultra-low power wireless monitoring of multiple vital signs - such as ECG, heart rate, body temperature, respiration and physical activity (via a 3-axis accelerometer) - and is currently being developed in both disposable and non-disposable body monitoring products. - Ends - About Toumaz Technology (www.toumaz.com) Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions. Toumaz's ultra low-power smart sensor interface and transceiver platform - the Sensium - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx) technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively. For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible better therapeutic outcomes. | papalpower | |
22/1/2008 08:43 | Was Strand Partners Limited,perhaps they were n't getting the message across. | spekky | |
19/1/2008 10:18 | super, plagiarism, always been my biggest fear with this company. | humbugg | |
16/1/2008 23:12 | Thought this might be of interest: "Microsoft is developing Big Brother-style software capable of remotely monitoring a worker's productivity, physical wellbeing and competence. The Times has seen a patent application filed by the company for a computer system that links workers to their computers via wireless sensors that measure their metabolism. The system would allow managers to monitor employees' performance by measuring their heart rate, body temperature, movement, facial expression and blood pressure. Unions said they fear that employees could be dismissed on the basis of a computer's assessment of their physiological state. [...]" | supernumerary | |
15/1/2008 14:24 | The lofty ambitions of one of our board members(and large shareholder). (just hit cancel if windows tells you to install language pack,it comes up in english anyway) | spekky | |
14/1/2008 09:55 | Anything else would be a waste........ | spekky | |
11/1/2008 18:57 | "looking at the next 24 months as a road to significant riches." Now, there's confidence for you...... Are you planning to spend it all on wine, women, and song...... | don muang | |
11/1/2008 18:51 | Not worried here (yet) - think this is the "life changer" I have been looking for during my last 10 years trading. Sitting on a good few now, and looking at the next 24 months as a road to significant riches. | the drewster | |
31/12/2007 08:41 | looks like we could be heading back to the 8p support level. CVS investments are looking very messy. | humbugg | |
27/12/2007 12:30 | In todays news and...... I think that should ensure that Sentinel will get some publicity with the launch of the new product in Q1 2008........ | spekky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions